Amarin Corporation Plc

Type: Company
Name: Amarin Corporation Plc
Nationality: Ireland
Web Address: http://www.amarincorp.com/
First reported 5 hours ago - Updated 5 hours ago - 1 reports

MannKind: Let It Dip A Bit More, Then Cover/Buy

By Quoth the Raven:It was just a couple of months ago that I was lambasted for suggesting that investors might find MannKind's (NASDAQ: MNKD ) FDA approval as a good time to short the stock. MannKind bulls didn't seem to think that an FDA approval would ... [Published BioPortfolio - 5 hours ago]
First reported Jul 26 2014 - Updated Jul 26 2014 - 1 reports

Women Thor

I found 2 women Thor walking around Comic-con!Photo 1 - Lori Amarin, Southern CaliforniaShe is a huge fan of Thor and Loki and made her costume.Photo 2 - Ashely Danielson, Santee CaliforniaShe didn't know about the new Thor before she started building ... [Published CNN - Jul 26 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Sofinnova Raises $500 Million Biotech Venture Fund

MENLO PARK, Calif.Sofinnova focuses exclusively on helping entrepreneurs build successful biotechnology companies. Consistent with recent funds, SVP IX will provide capital primarily to companies with promising later stage clinical programs, along with ... [Published Bio-Medicine - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Novasep to keep supplying Amarin with Vascepa API

Novasep has confirmed it will keep supplying Amarin with omega-3 API as the US FDA withdraws special status afforded to Vascepa trial.Last yesterday Amarin revealed that the US Food and Drug Administration (FDA) has cancelled the special protocol assessment ... [Published Outsourcing Pharma - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

ARM Holdings Leads Gains Among European ADRs on Q2 Profit Beat; Energy Companies Rise With Oil Prices

European ADRs gained 0.9% on average to the highest since July 16, as measured by the Bank of New York Mellon Europe ADR Index, compared with a 0.6% gain for the S&P 500 Stock Index. Europe ADR advancers led decliners 80 to 25.ARM Holdings rose 5.8% to ... [Published Nasdaq - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar?

By biotech /'>Scrying Biotech:Amarin (NASDAQ: AMRN ) president and chief executive officer, John Thero has a performance history predicated on poor decision-making. He's been instrumental in bringing the company and perhaps the most important drug ... [Published BioPortfolio - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Amarin: Will The Lamb Of Ireland Bleat Or The Lion Of The People Roar?

Summary Amarin president, John Thero is hinting at mounting a 1st Amendment challenge to the FDA's off-label regulatory laws as a last resort, when he should be exercising free speech now. I'll show you how the FDA unjustly deprived Amarin of Vascepa ... [Published Seeking Alpha - Jul 21 2014]
First reported Jul 17 2014 - Updated Jul 17 2014 - 1 reports

Health Care Sector Stocks Technical Review: Valeant Pharma, Teva Pharma Industries, Novo Nordisk, Curis, and Amarin

On Wednesday, Valeant Pharmaceuticals International Inc.'s stock recorded a trading volume of 2.97 million shares, lower than its three months average volume of 3.48 million shares. The stock finished the day at $121.71 Shares in Teva Pharmaceutical Industries ... [Published Pettinga Financial Advisors - Jul 17 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

AMARIN CORP PLC\UK FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. Amarin Corporation plc (the "Company") held its 2014 Annual General Meeting of Shareholders (the "Annual Meeting") on July 7, 2014. There were ... ... [Published Crawford Financial Planning - Jul 10 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 2 reports

14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014

07/10/14 - 11:54 AM EDTBOSTON ( TheStreet ) -- Listed below are 14 biotech and drug stock catalysts for the remainder of 2014. Healthcare investors (and traders) have had a lot to work with so far this year, and the next six months promises to be equally ... [Published TheStreet.com - Jul 10 2014]
First reported Jul 02 2014 - Updated Jul 02 2014 - 1 reports

Could Amarin Return From The Dead?

After Amarin (AMRN) failed to gain FDA approval for a sNDA that would’ve allowed its triglyceride-lowering omega-3 drug Vascepa to be marketed to patients with “high” TG levels (200-500 mg/dL), the market pretty much left the stock for dead after it dropped ... [Published BioMedReports - Jul 02 2014]
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

AMARIN : Gets Together with 'Pawn Stars' Rick Harrison

Amarin is teaming with Rick Harrison from the television show "Pawn Stars," to launch Lower My Trigs.In its release, Amarin said that the national awareness campaign focuses on seeking treatment for very high triglycerides (VHTG) ( greater than 500 mg/dL), ... [Published 4 Traders - Jul 01 2014]

Quotes

"Only in a frothy, retail-driven (and now Tweet-driven) market can a stock like MannKind exist with a $4.3 BILLION valuation and in our view no clear prospects of revenue" Tourbillon Capital Partners wrote in a letter to investors obtained by CNBC.com. Tourbillon manages $1...
"CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patients lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. (SOURCE: Yahoo FinanceFinance Stock Summary CDNA )"
"We value the support that our returning limited partners and new investors have shown for our strategy and the Sofinnova team" commented Jim Healy
...returning limited partners and new investors have shown for our strategy and the Sofinnova team," commented Jim Healy, General Partner, Sofinnova. "Sofinnova is proud to partner with talented entrepreneurs who are focused on developing innovative medicines that can positively impact patient care. We remain committed to working with our collective network to identify and develop important new drugs, build successful companies, and continue to generate significant returns for our investors."

More Content

All (108) | News (75) | Reports (0) | Blogs (11) | Audio/Video (0) | Fact Sheets (4) | Press Releases (16)
sort by: Date | Relevance
THE ROYAL BARGE PROCESSION THE PRIDE OF THAILAND [Published NowTravelAsia - 5 hours ago]
MannKind: Let It Dip A Bit More, Then Cover/Buy [Published BioPortfolio - 5 hours ago]
MannKind: Let It Dip A Bit More, Then Cover/Buy [Published Seeking Alpha - 8 hours ago]
Women Thor [Published CNN - Jul 26 2014]
Novasep to keep supplying Amarin with Vascepa API [Published Outsourcing Pharma - Jul 23 2014]
Despite A Bumpy Road Ahead I'm Bullish On CareDx [Published Seeking Alpha - Jul 23 2014]
Sofinnova Raises $500 Million Biotech Venture Fund [Published Bio-Medicine - Jul 23 2014]
Sofinnova Raises $500 Million Biotech Venture Fund [Published TickerTech.com - Jul 23 2014]
Sofinnova closes $500M venture fund, keeps late... [Published FierceBiotech - Jul 23 2014]
ARM Holdings Leads Gains Among European ADRs on... [Published Nasdaq - Jul 22 2014]
MYOS Corp. Tackles Muscles Health [Published Seeking Alpha - Jul 22 2014]
Amarin: Will The Lamb Of Ireland Bleat Or The L... [Published BioPortfolio - Jul 21 2014]
Amarin: Will The Lamb Of Ireland Bleat Or The L... [Published Seeking Alpha - Jul 21 2014]
World Junior Championship: Hillier in contentio... [Published Noodls - Jul 18 2014]
Health Care Sector Stocks Technical Review: Val... [Published Pettinga Financial Advisors - Jul 17 2014]
Health Care Sector Stocks Technical Review: Val... [Published Financial Services - Jul 17 2014]
Criticise grouchy Matt Peranee at your peril [Published The Nation - Thailand - Jul 16 2014]
Shire Retreats for Second Day Since Abbvie's Re... [Published Nasdaq - Jul 16 2014]
FDA approves Astrazeneca’s fish oil drug [Published New Hope 360 - Jul 15 2014]
Analysis Questions Beta-blockers in Stable CHD ... [Published General Medicine eJournal - Jul 14 2014]
Minerva Neurosciences Announces Appointment Of ... [Published BusinessWeek - Jul 14 2014]
Oris celebrates 110th anniversary [Published Bangkok Post - Jul 12 2014]
Thirst for HD will fuel sales of satellite TV r... [Published The Nation - Thailand - Jul 11 2014]
AMARIN CORP PLC\UK FILES (8-K) Disclosing Submi... [Published Crawford Financial Planning - Jul 10 2014]
14 Insanely Important Biotech/Drug Trading Cata... [Published TheStreet.com - Jul 10 2014]
14 Insanely Important Biotech/Drug Trading Cata... [Published The Street Latest - Jul 10 2014]
Abingworth promotes Ken Haas and Vin Miles to p... [Published PE Hub Blog - Jul 10 2014]
Abingworth Promotes Ken Haas and Vin Miles to P... [Published Wall Street Select - Jul 10 2014]
Abingworth Promotes Ken Haas and Vin Miles to P... [Published Scottrade - Jul 10 2014]
OVERNIGHT HEALTHCARE: Senate Dems unveil bill t... [Published The Hill - Jul 10 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Abingworth promotes Ken Haas and Vin Miles to p... [Published PE Hub Blog - Jul 10 2014]
Abingworth has promoted Ken Haas and Vin Miles to partners. They are both based in the US where they source and manage deals including early stage and late stage venture capital, venture growth and public market investments as well as VIPEs (venture ...
Did Pawn Star Rick Harrison Ask His Daddy About... [Published Pharma Marketing Blog - Jun 25 2014]
Cable-TV star Rick Harrison (host of the show Pawn Stars ) is now officially a celebrity spokesperson for Amarin's Omega-3 Vascepa brand Rx drug. A few minutes ago, Harrison made the official announcement via his @GoldSilverPawn Twitter account, ...
Rick Harrison of Television's "Pawn Stars®" Dis... [Published PR Newswire: Entertainment & Media - Jun 25 2014]
NEW YORK, June 25, 2014 /PRNewswire/ -- Amarin Corporation, plc (Nasdaq: AMRN), today announced a national partnership with Rick Harrison, star of the hit television show "Pawn Stars®," in launching Lower My Trigs™, a national awareness campaign about ...
Amarin Announces Publication of Case Study Resu... [Published Marketwire - Breaking News Releases - Jun 11 2014]
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 11, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today ...
Amarin to Present at the Goldman Sachs 2014 Glo... [Published Marketwire - Breaking News Releases - Jun 04 2014]
BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - June 04, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today ...
1 2 3

Press Releases

sort by: Date | Relevance
Health Care Sector Stocks Technical Review: Val... [Published Financial Services - Jul 17 2014]
Stock Watchout on Biotech Industry -- Research ... [Published Financial Services - Jun 11 2014]
Technical Pulse on Active Equities -- Research ... [Published Financial Services - May 16 2014]
Amarin Announces Private Exchange Transactions ... [Published GlobeNewswire: Acquisitions News - May 15 2014]
Amarin Reports First Quarter 2014 Financial Res... [Published GlobeNewswire: Advertising News - May 09 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.